Hematology/Oncology at Sutter Pacific Medical Foundation

Oncology

Dr. Stephanie J. Jeske, MD


Stephanie Jeske is an expert in the field of Oncology. She went to Indiana University School of Medicine. Indiana University School of Medicine is ranked 45/47 in Research/PrimaryCare. She received awards:"Meaningful Use Stage 1 Certification". Doctor Stephanie J. Jeske, MD is a published doctor and has 2 publications published. The lastest was: 'A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981.' Stephanie J. Jeske, MD is registered with Medicare.



Publications


Schools


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Hospital


Drug Facts


NPI NUMBER   1194942813
NPPES Provider LastName   JESKE
NPPES Provider FirstName   STEPHANIE
NPPES Provider ZIPCode   950515173
NPPES Provider State   CA
Specialty Description   Hematology/Oncology
Total Claim Count   538.0
Distinct Opioid Count   1.0
Opioid Claim Count   34.0
Percent Opioid Claims   6.32

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1194942813
Last Name Of The Provider JESKE
First Name Of The Provider STEPHANIE
View All

Similar Doctors


Dr. Raymond Liu, MD
Dr. Usha K. Sunkara, MD
This Doctor is OpenDoctor Recommended.
Dr. Junming Fang, MD
This Doctor is OpenDoctor Recommended.
Dr. Lori A. Kunkel, MD
Dr. Stephen A. Sherwin, MD
This Doctor is OpenDoctor Recommended.
Dr. Wei Wang, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Andrew H. Ko, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Kristen M. Hege, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Robert A. Bok, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Sue Kim, MD
Dr. Daniel W. Sherbenou, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications


Doctor Directory | TOS | twitter | FB | Angel | blog